Call us free on 0800 862 0373

Sign in to view your quotes
Email address:
Password or PIN:

Forgotten your password? Reset it here.

Breast cancer drug Avastin turned down for use on the NHS

Published on 28/08/2012

Breast cancer patients will now only be able to access Avastin through private health insurance or through the Cancer Drugs Fund, after NICE turns it down for widespread use on the NHS.

Avastin (bevacizumab) is a drug that works by starving cancerous tumours of blood. It has been licensed for prescription in the UK for breast cancer that had spread to other parts of the body, in combination with a type of chemotherapy called capecitabine.

However, the National Institute for Health and Clinical Excellence (NICE) has ruled that it does not help improve patients’ quality of life of provide value for money, and therefore will not be made routinely available on the NHS. Sir Andrew Dillon, NICE's chief executive, said:

"We can't recommend a drug that has not been shown to work as well as, or better than, current treatments and costs much more.”

It will now be the responsibility of NHS trusts in England to make decisions locally on the funding of Avastin. Doctors will have to apply on behalf of their patients to an ‘exceptional case’ committee or to the Cancer Drugs Fund.

However, patients with private health insurance could still have access to Avastin through their policy. Many health insurers cover the cost of licensed drugs, even if they aren’t approved for widespread use on the NHS.

Roche, which manufactures Avastin, said it was disappointed by the decision from NICE and criticised the way the organisation had reviewed data about the drug's effectiveness. A spokeswoman said:

"The decision by NICE means women in England with advanced breast cancer and who have limited treatment options available to them will instead have to rely on their clinicians' successful application to the Cancer Drugs Fund in order to receive treatment with Avastin.”

NICE reviewed four clinical studies of Avastin in women with breast cancer and found the drug does not prolong overall survival or provide a sufficient benefit in slowing disease progression to outweigh the "significant risk" to patients.

© ActiveQuote Ltd. 2012


Categories:  Medical
Breast cancer drug Avastin turned down for use on the NHSBreast cancer patients will now only be able to access Avastin through private health insurance or through the Cancer Drugs Fund, after NI    tweet it on twittershare with your friends on Facebookshare with your friends on MySpaceBlog it on your LinkedIn profile
 

No.1 health insurance broker as rated by customers

I found the quality of service to be very helpful, and pretty much above my expectation. I'd recommend anyone to use ActiveQuote.

Review centre member

Very helpful and polite and always try their best to obtain the best quotes. Have been using them for the last 3 years and will continue to use them in the future.

Review centre member

A great service from the initial call, to finalising the agreement. I would highly recommend to my family and friends.

Review centre member

Proactive, efficient, and offered me insurance I need. I would say half price I would end up paying if I did it by myself. Many thanks.

Review centre member

Excellent service. Explained everything in detail and really helped to find the right insurance best suited to my needs - which wasn't necessarily the most expensive. 

Review centre member

Good value and the advisor was very helpful and recommended the best policy for my grandson. I would definitely use this service again and recommend to others.

Review centre member

We were contacted in good time to make a knowledgable choice. We were given plenty of options with lots of information to enable us to make the right choice.

Review centre member

The service I received was excellent, the staff member was very efficient and knowledgable. She went out of her way to get the best policy for me.

Review centre member

Great service. I really appreciated the help provided by Active Quote to arrange health insurance. The agent was very informative and proactive. Many thanks!

Review centre member

I received excellent care and attention from the first phone call till the last. Friendly, efficient and patient.

Review centre member
 
This site is operated by Insurance Broker ActiveQuote Ltd registered in England & Wales company number 6765845.
Authorised and Regulated by the Financial Conduct Authority (FCA). Firm reference number 501109 as detailed on the Financial Services Register. Please read our Key Facts document.
For information about your rights as a consumer visit Citizens Advice.

Our insurance comparison service is free and easy for you to use, but you are responsible for making sure all your information is entered correctly, and for choosing your insurer.

This site uses cookies in order to work correctly - these are not harmful and do not contain personal information. By using this site you consent to this. I understand  Tell me more

please wait ...